Cell Act Pharma

CellAct Pharma GmbH was founded in 2007 by Fritz Kopitzki and Nalân Utku as a venture capital-backed biotechnology company. CellAct is dedicated to developing innovative therapies for the treatment of various cancers. The development team consists of experienced advisors with extensive industry expertise in the field of oncology, as well as CRO and CMO experience. Dr. Nalân Utku, founder and CEO of CellAct, brings together outstanding experience and a successful track record in the development of treatments for oncology and inflammatory diseases.